- Oral presentation
- Open Access
MOH Drug SCM Strategy Development: a means to identify human resource training needs in Indonesia
© Sosialina et al; licensee BioMed Central Ltd. 2014
- Published: 17 December 2014
- Supply Chain Management
- Human Resource Development
- Situation Analysis
- Drug Management
- Resource Issue
To develop the National Drug Supply Chain Management Strategy (SCM) Strategy, BinFar formed a strategy team made up of key SCM partners and staff. A drug SCM situation analysis was undertaken in 14 units within the MOH, exploring SCM issues and concerns, including staff development. Based on the results of the situation analysis, a stakeholders meeting was held to determine the core substance of the strategy and build a consensus on the key issues, including human resource development.
A national drug SCM strategy was developed to ensure drug availability, drug quality, and drug affordability for the public. The strategy framework included challenges and opportunities, a Vision, Mission and Goal statements, and developed strategy components based on the traditional SCM cycle. Based on the situation analysis results and in depth discussion with stakeholders, the strategy reviews each SCM cycle component regarding challenges and current practices and experiences. Based on these factors, a specific component strategy was developed with several strategic measures. It was concluded that human resource development was essential to support the entire drug management system.
Development of pharmacists competent as drug managers at all levels, including at health service facilities in hospitals and health centres.
Trained SCM personnel to ensure the smooth running of the drug management information systems.
Complete task analysis for every SCM competency required and develop pre-service and in-service training for pharmacists.
Stipulate a personnel standard for service locations that include pharmacists trained in SCM.
A national drug SCM strategy is a good opportunity to identify human resource SCM needs.
Obtaining consensus across programs and departments for a national drug SCM strategy requires strong baseline data and considerable dialogue.
Human resource issues and solutions are the backbone of a national drug SCM strategy.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.